Organization · Corporate Venture Capital
Sophia Innovation Capital
Sophia Innovation Capital is the corporate venture arm of Laboratorios Sophia, focused on early-stage investments in the ophthalmology and vision care sectors. Based in Zapopan, Mexico, it leverages the parent company's extensive industry expertise to support innovative projects.
Overview
What Sophia Innovation Capital does
What Sophia Innovation Capital is
Sophia Innovation Capital is the corporate venture arm of Laboratorios Sophia, focused on early-stage investments in the ophthalmology and vision care sectors. Based in Zapopan, Mexico, it leverages the parent company's extensive industry expertise to support innovative projects.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- May 4, 2026
Official channels
Find Sophia Innovation Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Sophia Innovation Capital as a funder
Investment thesis
Sophia Innovation Capital is the early stage investment area of Laboratorios Sophia, focusing on investments in new molecules and early-stage clinical innovations that improve human vision.
Focus narrative
The fund specializes in projects related to vision services, particularly in areas such as glaucoma, retina, dry eye, and refractive error. Sophia Innovation Capital engages with startups at various stages of development, including pre-clinical, early clinical trials, and late-stage development, as well as products that are already generating income.
Value beyond capital
Sophia Innovation Capital provides portfolio companies with access to Laboratorios Sophia's 75 years of industry experience, along with its clinical, regulatory, manufacturing, and distribution networks in the vision care sector. This strategic partnership enhances the operational capabilities of startups in the ophthalmology space.
Focus and fit
- Stages
- Seed · Series A
- Regions
- Latam · North America · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 3
Portfolio context
Notable portfolio company includes Osheru, an ophthalmic startup that received investment in a Seed round in July 2024.
Common questions
What to know about Sophia Innovation Capital
Upseed classifies Sophia Innovation Capital under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.